Market Access News | pharmaphorum

News

OTC birth control arrives in the US

The first-ever over-the-counter contraceptive pill has finally been approved for sale in the US, extending the choice of birth control options available to women.

News

NHS may double subscription rate for novel antibiotics

The yearly subscription-style payments made by NHS England to developers of novel antibiotics could be doubled from £10 million to £20 million in some cases, according to

News

Takeda pulls its dengue vaccine filing from FDA

Takeda has unexpectedly withdrawn its marketing application with the FDA for dengue fever vaccine TAK-003 and said it will reconsider whether it will attempt to bring it t

News

Embattled Better gets FDA okay for lead DTx product

Digital health company Better Therapeutics has the FDA approval for lead digital therapeutic (DTx) AspyreRx for type 2 diabetes it was hoping for – but now it has to conve

News

EMA probes suicide risk with Novo Nordisk obesity drugs

The European Medicines Agency (EMA) has started a review of two Novo Nordisk drugs used to treat obesity and those overweight, following reports of suicidal thoughts or se

News

UK High Court bars generics trade body from VPAS talks

An attempt by the British Generic Manufacturers Association (BGMA) to get a seat at the negotiation table for the new Voluntary Scheme for Branded Medicines Pricing and Ac

OTC birth control arrives in the US

NHS may double subscription rate for novel antibiotics

Takeda pulls its dengue vaccine filing from FDA

Embattled Better gets FDA okay for lead DTx product

EMA probes suicide risk with Novo Nordisk obesity drugs

UK High Court bars generics trade body from VPAS talks

UK seeks views on indefinite CE marks for medical devices

How to meet your physicians where they are online

News

Editor's Picks